These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6610186)

  • 1. Vasopressin perfusion of esophageal varices in cirrhotic patients: cineangiographic study.
    Valla D; Huet PM; LaFortune M; Marleau D
    Radiology; 1984 Jul; 152(1):45-9. PubMed ID: 6610186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of blood flow to vasopressin in the collateral left gastric vein in patients with portal hypertension.
    Matsutani S; Mizumoto H; Fukuzawa T; Ohto M; Okuda K
    J Hepatol; 1995 Nov; 23(5):557-62. PubMed ID: 8583144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vasopressin on left gastric venous flow in cirrhotic patients with esophageal varices.
    Ohnishi K; Sato S
    Am J Gastroenterol; 1990 Mar; 85(3):293-5. PubMed ID: 2178400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vasopressin on esophageal varices blood flow in patients with cirrhosis: comparisons with the effects on portal vein and superior mesenteric artery blood flow.
    Iwao T; Toyonaga A; Oho K; Shigemori H; Sakai T; Tayama C; Masumoto H; Sato M; Tanikawa K
    J Hepatol; 1996 Oct; 25(4):491-7. PubMed ID: 8912148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Findings in percutaneous transhepatic portography and variceal bleeding in cirrhosis.
    Burcharth F; Sørensen TI; Andersen B
    Surg Gynecol Obstet; 1980 Jun; 150(6):887-90. PubMed ID: 6966428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices.
    Lunderquist A; Vang J
    N Engl J Med; 1974 Sep; 291(13):646-9. PubMed ID: 4546968
    [No Abstract]   [Full Text] [Related]  

  • 7. Color Doppler ultrasonography is reliable in assessing the risk of esophageal variceal bleeding in patients with liver cirrhosis.
    Plestina S; Pulanić R; Kralik M; Plestina S; Samarzija M
    Wien Klin Wochenschr; 2005 Oct; 117(19-20):711-7. PubMed ID: 16416372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How the lower oesophageal sphincter affects submucosal oesophageal varices.
    Miskowiak J
    Lancet; 1978 Dec; 2(8103):1284-5. PubMed ID: 82785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoproterenol in offsetting adverse effects of vasopressin in cirrhotic patients.
    Sirinek KR; Thomford NR
    Am J Surg; 1975 Feb; 129(2):130-6. PubMed ID: 1078945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vasopressin on portal pressure during hemorrhage from esophageal varices.
    Ready JB; Robertson AD; Rector WG
    Gastroenterology; 1991 May; 100(5 Pt 1):1411-6. PubMed ID: 2013386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of portal hypertension. Selective mesenteric arterial infusion of vasopressin.
    Nusbaum M; Younis MT; Baum S; Blakemore WS
    Arch Surg; 1974 Mar; 108(3):342-7. PubMed ID: 4544313
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of vasopressin on portal venous pressure.
    Kallio H; Lempinen M
    Acta Chir Scand; 1983; 149(1):49-52. PubMed ID: 6601347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective arterial infusion of vasopressin in the treatment of acute gastrointestinal hemorrhage.
    Covey TH; Baue AE
    Angiology; 1974 Jan; 25(1):54-60. PubMed ID: 4544188
    [No Abstract]   [Full Text] [Related]  

  • 14. Isobutyl 2-cyanoacrylate (bucrylate) in obliteration of gastric coronary vein and esophageal varices.
    Lunderquist A; Börjesson B; Owman T; Bengmark S
    AJR Am J Roentgenol; 1978 Jan; 130(1):1-6. PubMed ID: 413393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous transhepatic portal venography in the diagnosis and management of gastroesophageal varices.
    Katzen BT; Passariello R; Rossi P; Simonetti G; Chang J
    South Med J; 1979 Aug; 72(8):942-5. PubMed ID: 314159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal and systemic effects of selective infusion of vasopressin into the superior mesenteric artery in cirrhotic patients.
    Millette B; Huet PM; Lavoie P; Viallet A
    Gastroenterology; 1975 Jul; 69(1):6-12. PubMed ID: 1150036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperdynamic circulation in the left gastric venous area in patients with portal hypertension: angiological assessment.
    Koyanagi N; Inokuchi K; Beppu K; Nagamine K; Hashizume M; Sugimachi K
    Jpn J Surg; 1985 Mar; 15(2):134-9. PubMed ID: 4010094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does intra-arterial vasopressin control gastrointestinal bleeding in cirrhotic patients?
    Mackenzie RL; Bury KD; Provan JL; St Louis E; Marcon N
    Can J Surg; 1977 Jul; 20(4):356-9. PubMed ID: 301427
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical use of vasopressin in the management of bleeding esophageal varices.
    Schweitzer EJ; Kerr JC; Swan KG
    Am Surg; 1982 Nov; 48(11):558-62. PubMed ID: 6983321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REDUCTION OF PORTAL VENOUS PRESSURE IN CIRRHOTIC PATIENTS WITH BLEEDING FROM OESOPHAGEAL VARICES, BY ADMINISTRATION OF A VASOPRESSIN DERIVATIVE, PHENYLALANINE-2-LYSINE-8-VASOPRESSIN.
    TSAKIRIS A; HAEMMERLI UP; BUEHLMANN A
    Am J Med; 1964 Jun; 36():825-39. PubMed ID: 14164148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.